Inventor · disambiguated record
John Poirier
Also filed as: POIRIER JOHN · POIRIER JOHN T · POIRIER JOHN THOMAS
5 granted patents·7 pending applications·11 citations·filing 2016–2025
74Inventor score
Top patents by PatentIndex Score
12 records- 0192US11096972B2Seneca Valley Virus (SVV) cellular receptor targeted oncotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Aug 24, 2021·4 cites·15 claims
- 0291US11738058B2Seneca valley virus (SVV) cellular receptor targeted oncotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Aug 29, 2023·2 cites·20 claims
- 0388US10537599B2Seneca valley virus (SVV) cellular receptor targeted oncotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Jan 21, 2020·4 cites·11 claims
- 0482US12472218B2Seneca valley virus (SVV) cellular receptor targeted oncotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Granted Nov 18, 2025·0 cites·4 claims
- 0578US12441789B2DLL3-targeting antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Oct 14, 2025·1 cites·17 claims
- 0662US2024216557A1Radioligand binding to anti-dll3 antibodies for pretargeted pet imaging and therapeutic uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0762US2024368269A1Anti-dll3 antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0854US2024115721A1Anti-dll3 antibody-drug conjugateMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 0954US2024115720A1Antibody-pyrrolobenzodiazepine derivative conjugateMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 1053US2024254564A1Methods for predicting and treating chemoresistance in small cell lung cancer patientsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 1146US2025236891A1Optimized retron editors for efficient genome engineering and delivery to mammalian cellsUNIV NEW YORK·Filed 2025·Application pending·0 cites
- 1243US2020171082A1Quantifying slfn11 protein for optimal cancer therapyNANTOMICS LLC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Poirier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →